Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | AAREYDRUGS Aarey Drugs & Pharmaceuticals Limited Pharma · Small | MEDICAMEQ Medicamen Biotech Limited Pharma · Small | BROOKS Brooks Laboratories Limited Pharma · Small | ALPA Alpa Laboratories Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 15 | 19 | 74 | 46 |
| Verdict | OVERVALUED | OVERVALUED | UNDERVALUED | FAIR VALUE |
| Style | OVERVALUED | OVERVALUED | Top Setup | Deep Value |
| Piotroski | 6/9 | 5/9 | 8/9 | 6/9 |
| Valuation | 3/30 | 4/30 | 27/30 | 26/30 |
| Growth | 2/25 | 5/25 | 18/25 | 11/25 |
| Quality | 0/20 | 0/20 | 13/20 | 0/20 |
| Balance Sheet | 6/15 | 9/15 | 11/15 | 10/15 |
| Cash Flow | 4/10 | 0/10 | 3/10 | 4/10 |
| Price | ₹80.24 | ₹239.75 | ₹68.23 | ₹69.36 |
| P/E | 57.40 | 33.30 | 8.22 | 9.62 |
| P/B | 1.51 | 1.18 | 1.64 | 0.78 |
| ROE | 2.75% | 3.95% | 22.30% | 8.39% |
| ROCE | 5.58% | 5.43% | 21.50% | 9.42% |
| Debt / Equity | 0.33 | 0.17 | 0.07 | 0.02 |
| FCF Yield | — | — | 2.97% | — |
| Dividend Y | — | 0.42% | — | — |
| Altman Z | 3.35 | 3.97 | 6.58 | 3.25 |
| Promoter % | 37.71% | 40.46% | 52.62% | 57.19% |
| Mkt Cap (₹Cr) | 228.00 | 321.00 | 202.00 | 144.00 |
| Graham # | ₹40.86 | ₹180.21 | ₹88.35 | ₹119.15 |
| Fair PE | 4.2 | 5.8 | 42.0 | 42.0 |
| MoS % | -1261.3% | -483.4% | +80.5% | +76.8% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startAAREYDRUGS125
MEDICAMEQ47
BROOKS49
ALPA61